Wolverine Trading’s Amedisys AMED Stock Holding History

Wolverine Trading’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,600	Closed	-$1.14M	–	4411
2022 Q1	$1.14M	Buy	+6,600	New	+$986K	﹤0.01%	2319
2020 Q4	–	Sell	-10,600	Closed	-$2.46M	–	4750
2020 Q3	$2.46M	Buy	+10,600	New	+$2.41M	0.01%	1328
2020 Q2	–	Sell	-23,800	Closed	-$4.28M	–	4519
2020 Q1	$4.28M	Sell	23,800 -3,600	-13%	-$640K	0.01%	850
2019 Q4	$4.58M	Buy	+27,400	New	+$4.08M	0.01%	1171
2019 Q3	–	Sell	-42,400	Closed	-$5.15M	–	4244
2019 Q2	$5.15M	Buy	+42,400	New	+$5.03M	0.01%	863
2019 Q1	–	Sell	-12,000	Closed	-$1.38M	–	4464
2018 Q4	$1.38M	Sell	12,000 -11,200	-48%	-$1.32M	﹤0.01%	1718
2018 Q3	$2.9M	Buy	+23,200	New	+$2.56M	0.01%	1365
2016 Q4	–	Sell	-6,600	Closed	-$312K	–	4392
2016 Q3	$312K	Buy	+6,600	New	+$329K	﹤0.01%	3180

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Wolverine Trading's AMED Position: Q2 2022 in Review

Wolverine Trading sold out of Amedisys (AMED) in Q2 2022, closing a stake of 3,282 shares — an estimated $567K sold.

Wolverine Trading first reported a position in AMED in Q3 2018 and held it in 5 quarters. The position peaked at $1.44M in Q3 2018. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

Wolverine Trading reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
Wolverine Trading sold 3,282 Amedisys shares in Q2 2022, an estimated $567K.
Wolverine Trading first reported a position in Amedisys in Q3 2018 and held it in 5 quarters.
Wolverine Trading's Amedisys position peaked at $1.44M in Q3 2018.
288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.